Jade Biosciences Inc
JBIOHealthcare|Biotechnology|USA
$20.94
-1.54 (-6.85%)
Tangible Book
$6.01
Clinical Trials (6)
| Trial | Conditions | Phase | Status | Enrollment | Design | Drug |
|---|---|---|---|---|---|---|
| NCT07541287 A Study of JADE101 in Participants With Immunoglobulin A Nephropathy | IgA Nephropathy | P2 | Recruiting | 30 | Open-label | JADE101 |
| NCT07059312 A Phase 1 Study of JADE101 in Healthy Participants | Healthy Volunteers | P1 | Active | 32 | RCT, Double-blind | JADE101, Placebo |
| NCT07533955 A Phase 1 Study of JADE201 in Participants With Rheumatoid Arthritis | Rhematoid Arthritis | P1 | Recruiting | 36 | RCT, Double-blind | JADE201, Placebo |
| NCT07525947 A Single Dose, Phase 1 Study of JADE101 in Healthy Japanese and Chinese Participants | Healthy Volunteers (HV) | P1 | Recruiting | 40 | Open-label | JADE101 |
| NCT03452280 Validation of the JADE wRAP™, a Novel Blood Pressure Measurement Device, Using the Same Arm Sequential Method | Blood Pressure | Unknown | 140 | — | — | |
| NCT07005921 Attention, Memory and Quality of Life in Post-COVID-19 Adults | Post-Acute COVID-19 Syndrome, Long COVID | N/A | Not Yet Recruiting | 60 | RCT, Double-blind | — |